使p53

Bibek Bhatta1, Tomer Cooks1

  • 1The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Cancer discovery
|July 7, 2023
PubMed
概括

研究人员通过研究其减少的瘤抑制活性,证实PADI4是TP53基因的标. 这一发现促进了对TP53-PADI4相互作用及其对患者生存和免疫治疗结果的潜在影响的理解.